Reply to “Routine Re-screening for Latent Tuberculosis Has Low Utility in Patients With Chronic Immune-Mediated Inflammatory Diseases Treated With Biologics: A Single Center Retrospective Cohort Study” - 30/11/22
Doi : 10.1016/j.jaad.2022.07.051
Urmi Khanna, MD a, Anthony P. Fernandez, MD, PhD b, c, ⁎ 
a Division of Dermatology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, New York
b Department of Dermatology, Cleveland Clinic, Ohio
c Department of Pathology, Cleveland Clinic, Ohio
∗Correspondence to: Anthony P. Fernandez, MD, PhD, Departments of Dermatology and Pathology, Cleveland Clinic, 9500 Euclid Avenue, A61, Cleveland, OH 44195Departments of Dermatology and PathologyCleveland Clinic9500 Euclid AvenueA61ClevelandOH44195
Key words : biologics, immune-mediated inflammatory diseases, latent tuberculosis screening, psoriasis, Quantiferon
| Funding sources: None. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2022
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 6
P. 1437-1438 - décembre 2022 Retour au numéro
Article précédent
- Dermatoscopic features differentiating among port wine stain, arteriovenous malformation, and capillary malformation-arteriovenous malformation syndrome: to detect potential fast-flow vascular malformations at an early stage
- Yi Sun, Lixin Su, Yunjie Zhang, Zhenfeng Wang, Shijie Chen, Hao Gu, Xiaojie Yue, Xiong Zhao, Xitao Yang, Deming Wang, Xindong Fan, Ren Cai
- Type 1 and type 2 psoriasis revisited: No association between age at onset and disease course
- Axel Svedbom, Mona Ståhle
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?